Mast Cell Mediators of Significance in Clinical Practice in Mastocytosis

Joseph H. Butterfield, Anupama Ravi, Thanai Pongdee

Research output: Contribution to journalArticle

11 Scopus citations

Abstract

Mast cells leave evidence, a “fingerprint,” of their participation in acute and chronic clinical events. That fingerprint is an elevation, either chronic or acute, in levels of their secreted mediators or their metabolites. Of these, only serum tryptase is currently one of the diagnostic criteria for systemic mastocytosis or mast cell activation. Combinations of easily obtained and quantified urinary mast cell mediator metabolite levels correlate well with bone marrow findings of systemic mastocytosis. By inhibiting synthesis of or blockading receptors to the elevated mast cell mediator, relief of clinical symptoms can often be achieved.

Original languageEnglish (US)
JournalImmunology and Allergy Clinics of North America
DOIs
StateAccepted/In press - Jan 1 2018

Keywords

  • 2,3,dinor-11βProstaglandin(PG) F2α
  • Histamine
  • Leukotriene(LT) E4
  • N-methylhistamine
  • Neuropeptide
  • Tryptase

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Mast Cell Mediators of Significance in Clinical Practice in Mastocytosis'. Together they form a unique fingerprint.

  • Cite this